Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Microwave freeze-thaw technique of injectable drugs. A review from 1980 to 2014.

Hecq JD, Godet M, Jamart J, Galanti L.

Ann Pharm Fr. 2015 Jun 4. pii: S0003-4509(15)00053-X. doi: 10.1016/j.pharma.2015.04.009. [Epub ahead of print]

PMID:
26051968
2.

Progress and problems with the use of suicide genes for targeted cancer therapy.

Karjoo Z, Chen X, Hatefi A.

Adv Drug Deliv Rev. 2015 May 22. pii: S0169-409X(15)00102-7. doi: 10.1016/j.addr.2015.05.009. [Epub ahead of print] Review.

PMID:
26004498
3.

Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Wilhelmus KR.

Cochrane Database Syst Rev. 2015 Jan 9;1:CD002898. doi: 10.1002/14651858.CD002898.pub5. Review.

PMID:
25879115
4.

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.

Vaziri S, Pezhman Z, Sayyad B, Mansouri F, Janbakhsh A, Afsharian M, Najafi F.

J Res Med Sci. 2014 Dec;19(12):1185-92. Review.

5.

Universal prophylaxis or preemptive strategy for cytomegalovirus disease after liver transplantation: a systematic review and meta-analysis.

Mumtaz K, Faisal N, Husain S, Morillo A, Renner EL, Shah PS.

Am J Transplant. 2015 Feb;15(2):472-81. doi: 10.1111/ajt.13044. Epub 2014 Dec 17.

PMID:
25522141
6.

Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.

Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, Craig ME, Rawlinson WD.

Rev Med Virol. 2014 Nov;24(6):420-33. doi: 10.1002/rmv.1814. Epub 2014 Oct 14. Review.

PMID:
25316174
7.

Review of clinical and basic approaches to corneal endotheliitis.

Inoue Y.

Cornea. 2014 Nov;33 Suppl 11:S3-8. doi: 10.1097/ICO.0000000000000228. Review.

PMID:
25170583
8.

Ablating adult neurogenesis in the rat has no effect on spatial processing: evidence from a novel pharmacogenetic model.

Groves JO, Leslie I, Huang GJ, McHugh SB, Taylor A, Mott R, Munafò M, Bannerman DM, Flint J.

PLoS Genet. 2013;9(9):e1003718. doi: 10.1371/journal.pgen.1003718. Epub 2013 Sep 5.

9.

[Clinical efficacy and safety of prolonged use of the valganciclovir for the treatment of cytomegalovirus disease in patients after kidney transplantation].

Kawalec P, Szkultecka-Debek M, Maks J, Paszulewicz A, Kaweczyńska-Lasoń A, Pilc A.

Pol Merkur Lekarski. 2013 Jul;35(205):10-3. Review. Polish.

PMID:
23984598
10.

[The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation].

Kawalec P, Holko P, Szkultecka-Debek M, Paszulewicz A, Boratyńska M, Głyda M, Ignacak E, Maks J, Russel-Szymczyk M, Kaweczyńska-Lasoń A.

Pol Merkur Lekarski. 2013 Jun;34(204):332-8. Polish.

PMID:
23882930
11.

Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients.

Razonable RR.

Infect Dis Clin North Am. 2013 Jun;27(2):317-42. doi: 10.1016/j.idc.2013.02.005. Epub 2013 Mar 26. Review.

PMID:
23714343
12.

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Owers DS, Webster AC, Strippoli GF, Kable K, Hodson EM.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD005133. doi: 10.1002/14651858.CD005133.pub3. Review.

PMID:
23450558
13.

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD003774. doi: 10.1002/14651858.CD003774.pub4. Review.

PMID:
23450543
14.

[Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].

Ferrés M, Nervi B, Ramírez P.

Rev Chilena Infectol. 2012 Sep;29 Suppl 1:S23-8. doi: 10.4067/S0716-10182012000500004. Review. Spanish.

15.

Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis.

Kalil AC, Mindru C, Botha JF, Grant WJ, Mercer DF, Olivera MA, McCartan MA, McCashland TM, Langnas AN, Florescu DF.

Liver Transpl. 2012 Dec;18(12):1440-7. doi: 10.1002/lt.23530. Review.

16.
17.

Evaluation of infections in the lung transplant patient.

Watkins RR, Lemonovich TL.

Curr Opin Infect Dis. 2012 Apr;25(2):193-8. doi: 10.1097/QCO.0b013e32834c54bc. Review.

PMID:
22123666
18.

Evidence based management guidelines for the detection and treatment of congenital CMV.

Kadambari S, Williams EJ, Luck S, Griffiths PD, Sharland M.

Early Hum Dev. 2011 Nov;87(11):723-8. doi: 10.1016/j.earlhumdev.2011.08.021. Epub 2011 Sep 29.

PMID:
21962770
19.

Medical and surgical interventions for hearing loss associated with congenital cytomegalovirus: a systematic review.

Shin JJ, Keamy DG Jr, Steinberg EA.

Otolaryngol Head Neck Surg. 2011 May;144(5):662-75. doi: 10.1177/0194599811399241. Review.

PMID:
21493333
20.

Effectiveness of valganciclovir 900 mg versus 450 mg for cytomegalovirus prophylaxis in transplantation: direct and indirect treatment comparison meta-analysis.

Kalil AC, Mindru C, Florescu DF.

Clin Infect Dis. 2011 Feb 1;52(3):313-21. doi: 10.1093/cid/ciq143. Epub 2010 Dec 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk